UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2022 | 2022-11-01 | Future report Set alerts | |
| Q2 2022 | 2022-08-10 | 0.26 | 0.26 |
| Q1 2022 | 2022-05-04 | 0.19 | 0.19 |
| Q4 2021 | 2022-02-23 | 0.10 | 0.10 |
| Q3 2021 | 2021-11-03 | 0.12 | 0.12 |
| Q2 2021 | 2021-08-04 | 0.17 | 0.17 |
| Q1 2021 | 2021-05-05 | 0.10 | 0.10 |
| Q4 2020 | 2021-02-24 | 0.07 | 0.07 |
| Q3 2020 | 2020-11-04 | 0.00 | 0.00 |
| Q2 2020 | 2020-08-05 | -0.03 | -0.03 |
| 2016-05-18 | Upgrade | Benchmark Co. | Hold to Buy | $6.00 |
| 2016-05-12 | Reiterated Rating | Canaccord Genuity | Hold | $7.00 |
| 2016-05-12 | Downgrade | Stephens | Overweight to Equal Weight | |
| 2016-03-06 | Initiated Coverage | Canaccord Genuity | Hold | $7.50 |
| 2016-03-03 | Lower Price Target | Benchmark Co. | Hold | $7.00 to $6.00 |
| 2016-01-29 | Initiated Coverage | Benchmark Co. | Hold | $7.00 |
| 2015-10-29 | Initiated Coverage | Canaccord Genuity | Hold | $7.50 |
| 2015-07-30 | Reiterated Rating | Canaccord Genuity | Hold | $7.50 |
| 2015-04-30 | Reiterated Rating | Canaccord Genuity | Hold | $7.30 |
| 2015-03-01 | Set Price Target | Canaccord Genuity | Hold | $6.00 |
| 2015-02-12 | Reiterated Rating | Canaccord Genuity | Hold | $6.00 |
| 2014-10-31 | Downgrade | Canaccord Genuity | Buy to Hold | $16.00 to $12.00 |
| 2014-10-31 | Downgrade | William Blair | Outperform to Market Perform | |
| 2014-08-01 | Lower Price Target | Canaccord Genuity | $21.00 to $16.00 | |
| 2014-04-29 | Boost Price Target | Canaccord Genuity | Buy | $20.00 to $21.00 |
| 2014-03-24 | Upgrade | William Blair | Market Perform to Outperform | |
| 2014-03-17 | Boost Price Target | Benchmark Co. | $15.00 to $21.00 | |
| 2014-03-17 | Upgrade | Canaccord Genuity | Hold to Buy | $14.00 to $20.00 |
| 2014-02-27 | Boost Price Target | Canaccord Genuity | $12.00 to $14.00 | |
| 2013-10-31 | Boost Price Target | Canaccord Genuity | Hold | $10.00 to $12.00 |
| 2012-11-01 | Downgrade | Canaccord Genuity | Buy to Hold | $8.25 to $7 |
| 2011-10-25 | Reiterated | The Benchmark Company | Buy | $10 to $12.50 |
| 2010-10-12 | Initiated | Morgan Joseph | Buy | $6.40 |
| 2010-05-11 | Initiated | Benchmark | Buy | $7 |
| 2009-08-17 | Reiterated | MDB Capital Group | Buy | $3.25 to $5 |
| 2008-07-31 | Reiterated | MDB Capital Group | Buy | $4.70 to $5.75 |
| 2007-08-07 | Reiterated | Needham & Co | Buy | $7 to $5 |
| 2007-02-08 | Reiterated | MDB Capital Group | Buy | $12.15 to $12.50 |
| 2016-05-18 | Upgrade | Benchmark Co. | Hold to Buy | $6.00 |
| 2016-05-12 | Reiterated Rating | Canaccord Genuity | Hold | $7.00 |
| 2016-05-12 | Downgrade | Stephens | Overweight to Equal Weight | |
| 2016-03-06 | Initiated Coverage | Canaccord Genuity | Hold | $7.50 |
| 2016-03-03 | Lower Price Target | Benchmark Co. | Hold | $7.00 to $6.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In STAA 223 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| BROADWOOD CAPITAL INC | 10.80M |
| BlackRock Inc. | 5.60M |
| Vanguard Group, Inc | 5.22M |
| BAILLIE GIFFORD & CO | 5.13M |
| STATE STREET CORP | 1.56M |
| BlackRock Fund Advisors | 1.28M |
| Palo Alto Investors, LLC | 1.10M |
| BlackRock Institutional Trust Company, N.A. | 1.01M |
| GENEVA CAPITAL MANAGEMENT LLC | 0.95M |
| GEODE CAPITAL MANAGEMENT, LLC | 0.87M |
| PRINCIPAL FINANCIAL GROUP INC | 0.69M |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 0.66M |
| MORGAN STANLEY | 0.61M |
| NORTHERN TRUST CORP | 0.61M |
| Artisan Partners Limited Partnership | 0.53M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| BROADWOOD PARTNERS LP | 28.13% (10855179) | BTX / QCOR / STAA / |
| Caldwell Barry G President and CEO | 0.80% (309839) | STAA / |
| Blickensdoerfer Hans-Martin VP, International Marketing | 0.36% (139200) | STAA / |
| BAILEY DON M | 0.25% (98137) | MNK / QCOR / STAA / |
| DUFFY DONALD | 0.15% (57000) | STAA / |
| Subrin Philippe VP Switzerland OP | 0.15% (56500) | STAA / |
| Mason Caren L | 0.13% (51513) | STAA / |
| LOGAN MARK B | 0.12% (46696) | STAA / VVUS / |
| Holliday Keith V.P., Chief Technology Officer | 0.11% (43781) | STAA / |
| Hughes Robin Vice President, Marketing | 0.11% (41075) | STAA / |
| ANDREWS DEBORAH J VP & Chief Financial Officer | 0.11% (40667) | BTX / STAA / |
| MORRISON DAVID R | 0.10% (40000) | STAA / |
| Gesten Samuel J VP, General Counsel | 0.10% (38316) | STAA / |
| Francese James E VP, Global Marketing | 0.09% (35870) | STAA / |
| Moore John C | 0.09% (33844) | STAA / |
| Brown Stephen P Vice President & Chief Financi | 0.08% (31881) | STAA / |
| SLACIK CHARLES P | 0.05% (18798) | QDEL / SQNM / STAA / |
| MEIER RICHARD A | 0.05% (18300) | BMRN / OMI / STAA / TFX / |
| Wall William P | 0.05% (17544) | HAYN / RESI / STAA / |
| FAGEN DONALD L V.P. Sales for N. America | 0.04% (16800) | STAA / |
| GOODMEN WILLIAM WALTER Global VP, Human Resources | 0.04% (15000) | STAA / |
| SILVERMAN LOU | 0.03% (11606) | QCOR / STAA / |
| Felberg Craig VP, R&D and Clinical Affairs | 0.02% (8700) | STAA / |
| Todd Donald J President, Asia/Pacific | 0.02% (7500) | STAA / |
| TUNSTALL KATHRYN | 0.02% (6085) | STAA / |
UM